Cargando…

Outcomes Analysis of Gynecologic Oncologic Reconstruction

BACKGROUND: Defects resulting from gynecologic oncology resections can range from small external defects to total exenterations, requiring complex pelvic reconstruction. We aim to investigate the patient and surgical factors that influence complication rates, reoperation rates, and length of stay. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Block, Lisa M., Hartmann, Emily C., King, Jason, Chakmakchy, Saygin, King, Timothy, Bentz, Michael L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382220/
https://www.ncbi.nlm.nih.gov/pubmed/30859025
http://dx.doi.org/10.1097/GOX.0000000000002015
_version_ 1783396627967377408
author Block, Lisa M.
Hartmann, Emily C.
King, Jason
Chakmakchy, Saygin
King, Timothy
Bentz, Michael L.
author_facet Block, Lisa M.
Hartmann, Emily C.
King, Jason
Chakmakchy, Saygin
King, Timothy
Bentz, Michael L.
author_sort Block, Lisa M.
collection PubMed
description BACKGROUND: Defects resulting from gynecologic oncology resections can range from small external defects to total exenterations, requiring complex pelvic reconstruction. We aim to investigate the patient and surgical factors that influence complication rates, reoperation rates, and length of stay. We hypothesize that this patient cohort will have high complication and reoperation rates that are likely most affected by their medical and extirpative surgery factors, with less direct impact from their reconstructive surgery procedures. METHODS: All cases of reconstruction following resection of a gynecological oncology tumor at the University of Wisconsin Hospital over the last 14 years were reviewed. Forty-three patients were identified who required 66 flaps for reconstruction. RESULTS: Mean follow-up period was 19 months. Overall complication rate was 65% and reoperation rate was 33%. Plastic surgery flap-specific complication and reoperation rates were 47% and 19%, respectively, and were not significantly associated with any patient risk factors. Flap reconstruction subtype was not associated with time to complete healing, complication rate, or reoperation. Prior chemotherapy was significantly correlated with increased rate of overall complication (P = 0.0253) and reoperation (P = 0.0448), but prior radiation was not. Mean hospital stay was 11 days (SD ± 9 d). Factors found to be significantly associated with an increase in hospitalization length were increasing number of comorbidities (P = 0.021), exenteration defects (P = 0.0122), myocutaneous flap reconstruction (P = 0.0003), radiation (P = 0.0004), and chemotherapy P = 0.0035). CONCLUSION: This patient cohort has an overall high complication and reoperation rate; however, increasingly complex reconstruction is not associated with significant differences in complication rates or reoperation.
format Online
Article
Text
id pubmed-6382220
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-63822202019-03-11 Outcomes Analysis of Gynecologic Oncologic Reconstruction Block, Lisa M. Hartmann, Emily C. King, Jason Chakmakchy, Saygin King, Timothy Bentz, Michael L. Plast Reconstr Surg Glob Open Original Article BACKGROUND: Defects resulting from gynecologic oncology resections can range from small external defects to total exenterations, requiring complex pelvic reconstruction. We aim to investigate the patient and surgical factors that influence complication rates, reoperation rates, and length of stay. We hypothesize that this patient cohort will have high complication and reoperation rates that are likely most affected by their medical and extirpative surgery factors, with less direct impact from their reconstructive surgery procedures. METHODS: All cases of reconstruction following resection of a gynecological oncology tumor at the University of Wisconsin Hospital over the last 14 years were reviewed. Forty-three patients were identified who required 66 flaps for reconstruction. RESULTS: Mean follow-up period was 19 months. Overall complication rate was 65% and reoperation rate was 33%. Plastic surgery flap-specific complication and reoperation rates were 47% and 19%, respectively, and were not significantly associated with any patient risk factors. Flap reconstruction subtype was not associated with time to complete healing, complication rate, or reoperation. Prior chemotherapy was significantly correlated with increased rate of overall complication (P = 0.0253) and reoperation (P = 0.0448), but prior radiation was not. Mean hospital stay was 11 days (SD ± 9 d). Factors found to be significantly associated with an increase in hospitalization length were increasing number of comorbidities (P = 0.021), exenteration defects (P = 0.0122), myocutaneous flap reconstruction (P = 0.0003), radiation (P = 0.0004), and chemotherapy P = 0.0035). CONCLUSION: This patient cohort has an overall high complication and reoperation rate; however, increasingly complex reconstruction is not associated with significant differences in complication rates or reoperation. Wolters Kluwer Health 2019-01-15 /pmc/articles/PMC6382220/ /pubmed/30859025 http://dx.doi.org/10.1097/GOX.0000000000002015 Text en Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Article
Block, Lisa M.
Hartmann, Emily C.
King, Jason
Chakmakchy, Saygin
King, Timothy
Bentz, Michael L.
Outcomes Analysis of Gynecologic Oncologic Reconstruction
title Outcomes Analysis of Gynecologic Oncologic Reconstruction
title_full Outcomes Analysis of Gynecologic Oncologic Reconstruction
title_fullStr Outcomes Analysis of Gynecologic Oncologic Reconstruction
title_full_unstemmed Outcomes Analysis of Gynecologic Oncologic Reconstruction
title_short Outcomes Analysis of Gynecologic Oncologic Reconstruction
title_sort outcomes analysis of gynecologic oncologic reconstruction
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382220/
https://www.ncbi.nlm.nih.gov/pubmed/30859025
http://dx.doi.org/10.1097/GOX.0000000000002015
work_keys_str_mv AT blocklisam outcomesanalysisofgynecologiconcologicreconstruction
AT hartmannemilyc outcomesanalysisofgynecologiconcologicreconstruction
AT kingjason outcomesanalysisofgynecologiconcologicreconstruction
AT chakmakchysaygin outcomesanalysisofgynecologiconcologicreconstruction
AT kingtimothy outcomesanalysisofgynecologiconcologicreconstruction
AT bentzmichaell outcomesanalysisofgynecologiconcologicreconstruction